[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-001", "question": "A 45-year-old male presents with syncope. ECG shows sinus rhythm with first-degree AV block and a right bundle branch block. Echocardiogram reveals a left ventricular ejection fraction (LVEF) of 42% with mild LV dilation. Genetic testing confirms a pathogenic variant in the LMNA gene (Lamin A/C). He has no history of sustained ventricular tachycardia. Which of the following is the most appropriate management?", "options": ["Implantation of a dual-chamber pacemaker", "Implantation of an implantable cardioverter-defibrillator (ICD)", "Implantation of an implantable loop recorder", "Initiation of Amiodarone", "Initiation of Metoprolol and reassessment of LVEF in 3 months"], "answer": "B", "answer_index": 1, "explanation": "Lamin A/C (LMNA) cardiomyopathy carries a disproportionately high risk of malignant ventricular arrhythmias and sudden cardiac death, often independent of the degree of LV dysfunction. Current guidelines recommend ICD implantation for patients with an LMNA mutation and risk factors such as AV block, male sex, or non-missense mutations, even if the LVEF is >35%. A pacemaker alone addresses the conduction disease but leaves the patient unprotected against the high risk of fatal ventricular arrhythmias.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. This item tests primary prevention ICD indication in LMNA cardiomyopathy. Key discriminating clues: pathogenic LMNA variant, syncope, first-degree AV block with RBBB, LVEF 42%, male sex. Current ESC/HRS guidelines endorse ICD for LMNA patients with LVEF <45% plus risk factors (conduction disease, male sex, non-missense mutations) or suspected arrhythmic syncope. The patient meets multiple criteria, making ICD (Option B) the clear best answer. Alternative analysis: Pacemaker (A) addresses conduction disease but not malignant VT/VF risk. Loop recorder (C) would delay definitive therapy in a high-risk patient. Amiodarone (D) is not primary prevention standard and has toxicity. Metoprolol (E) is appropriate for HF but insufficient for SCD prevention. No logical flaws: options are distinct, one best answer exists, and the key matches. Medical accuracy is excellent: aligns with 2021 ESC cardiomyopathy guidelines and 2022 HRS consensus. The teaching point about arrhythmic risk independent of EF is accurate and board-relevant. Minimal fix: specify 'presumed arrhythmic syncope' to strengthen the indication, though current phrasing is acceptable.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. This item tests primary prevention ICD indication in LMNA cardiomyopathy. Key discriminating clues: pathogenic LMNA variant, syncope, first-degree AV block with RBBB, LVEF 42%, male sex. Current ESC/HRS guidelines endorse ICD for LMNA patients with LVEF <45% plus risk factors (conduction disease, male sex, non-missense mutations) or suspected arrhythmic syncope. The patient meets multiple criteria, making ICD (Option B) the clear best answer. Alternative analysis: Pacemaker (A) addresses conduction disease but not malignant VT/VF risk. Loop recorder (C) would delay definitive therapy in a high-risk patient. Amiodarone (D) is not primary prevention standard and has toxicity. Metoprolol (E) is appropriate for HF but insufficient for SCD prevention. No logical flaws: options are distinct, one best answer exists, and the key matches. Medical accuracy is excellent: aligns with 2021 ESC cardiomyopathy guidelines and 2022 HRS consensus. The teaching point about arrhythmic risk independent of EF is accurate and board-relevant. Minimal fix: specify 'presumed arrhythmic syncope' to strengthen the indication, though current phrasing is acceptable.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-002", "question": "A 68-year-old male presents with a 3-week history of brief, involuntary jerking movements of his right face and arm, occurring up to 40 times per day. He remains conscious during these events. Interictal EEG and brain MRI are unremarkable. He is beginning to show signs of short-term memory impairment. Which of the following is the most appropriate initial treatment?", "options": ["Levetiracetam", "Carbamazepine", "Intravenous Methylprednisolone", "Tissue Plasminogen Activator (tPA)", "Haloperidol"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation is classic for faciobrachial dystonic seizures (FBDS), which are pathognomonic for Anti-LGI1 encephalitis (a form of limbic encephalitis). These seizures are characteristically resistant to standard anti-epileptic drugs but respond dramatically to immunotherapy (steroids, IVIG). Early recognition and treatment with immunotherapy are crucial to prevent the progression to severe cognitive impairment and full-blown limbic encephalitis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": The vignette describes a 68-year-old man with brief, frequent, unilateral facial and arm jerking movements, preserved consciousness, normal interictal EEG and MRI, and emerging short-term memory deficits. This constellation is highly suggestive of faciobrachial dystonic seizures (FBDS) associated with anti-LGI1 encephalitis. The key discriminating features are the semiology (brief, dystonic, unilateral), frequency, lack of EEG correlate, and cognitive decline. The correct answer is immunotherapy—intravenous methylprednisolone—because FBDS are notoriously refractory to conventional antiepileptic drugs (AEDs) but respond promptly to steroids. Levetiracetam and carbamazepine (A, B) are AEDs that would be appropriate for focal seizures but are ineffective for FBDS. Haloperidol (E) treats psychosis, not seizures or autoimmune encephalitis. tPA (D) is for acute ischemic stroke and is irrelevant. The item is internally consistent, the stem provides sufficient clues to identify FBDS, and the keyed answer aligns with current consensus that early immunotherapy is the treatment of choice. No major medical inaccuracies are present. The question is well-constructed and board-relevant.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": The vignette describes a 68-year-old man with brief, frequent, unilateral facial and arm jerking movements, preserved consciousness, normal interictal EEG and MRI, and emerging short-term memory deficits. This constellation is highly suggestive of faciobrachial dystonic seizures (FBDS) associated with anti-LGI1 encephalitis. The key discriminating features are the semiology (brief, dystonic, unilateral), frequency, lack of EEG correlate, and cognitive decline. The correct answer is immunotherapy—intravenous methylprednisolone—because FBDS are notoriously refractory to conventional antiepileptic drugs (AEDs) but respond promptly to steroids. Levetiracetam and carbamazepine (A, B) are AEDs that would be appropriate for focal seizures but are ineffective for FBDS. Haloperidol (E) treats psychosis, not seizures or autoimmune encephalitis. tPA (D) is for acute ischemic stroke and is irrelevant. The item is internally consistent, the stem provides sufficient clues to identify FBDS, and the keyed answer aligns with current consensus that early immunotherapy is the treatment of choice. No major medical inaccuracies are present. The question is well-constructed and board-relevant.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-003", "question": "A 55-year-old female is admitted to the ICU with sepsis and severe malnutrition. She has a history of chronic back pain managed with acetaminophen. Arterial blood gas shows pH 7.26, pCO2 28 mmHg, HCO3 12 mEq/L. Serum chemistry shows Na 140, Cl 104, BUN 18, Cr 0.8. Lactate is 1.1 mmol/L. Serum ketones are negative. Measured serum osmolality is 295 mOsm/kg (calculated 290). Which of the following is the most likely etiology of her metabolic acidosis?", "options": ["Methanol intoxication", "D-lactic acidosis", "Pyroglutamic acidosis (5-oxoproline accumulation)", "Propylene glycol toxicity", "Salicylate toxicity"], "answer": "C", "answer_index": 2, "explanation": "The patient has a high anion gap metabolic acidosis (AG = 24) with a normal lactate, no ketones, normal renal function, and a normal osmol gap (ruling out toxic alcohols like methanol or propylene glycol). The combination of chronic acetaminophen use, sepsis, and malnutrition leads to glutathione depletion, causing a disruption in the gamma-glutamyl cycle and accumulation of 5-oxoproline (pyroglutamic acid). This is an under-recognized cause of high anion gap acidosis in this specific patient population.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": The question asks for the most likely etiology of a high anion gap metabolic acidosis (HAGMA) in a critically ill, malnourished patient on chronic acetaminophen. Key discriminating findings: pH 7.26, HCO3 12, AG = Na - (Cl + HCO3) = 140 - (104 + 12) = 24 (elevated); lactate normal; ketones negative; normal renal function; osmol gap = measured - calculated = 295 - 290 = 5 (normal). The keyed answer C (pyroglutamic acidosis) fits: chronic acetaminophen depletes glutathione, and malnutrition/sepsis further impair the gamma-glutamyl cycle, leading to 5-oxoproline accumulation. The normal osmol gap correctly excludes methanol (A) and propylene glycol (D). D-lactic acidosis (B) is associated with short-gut syndrome or high carbohydrate loads, not this presentation. Salicylate toxicity (E) would typically cause a mixed respiratory alkalosis/metabolic acidosis and often presents with tachypnea, tinnitus, or coagulopathy—none mentioned. The stem provides sufficient detail to select a unique best answer. No contradictions. The explanation is accurate and aligns with current understanding of pyroglutamic acidosis pathophysiology. Minor nuance: the BUN/Cr ratio is not markedly elevated, but this does not detract from the core logic. The item is board-style and clinically realistic. Logical validity: V. Verdict: Correct best answer. Medical accuracy: accurate. Minimal fix: none required.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": The question asks for the most likely etiology of a high anion gap metabolic acidosis (HAGMA) in a critically ill, malnourished patient on chronic acetaminophen. Key discriminating findings: pH 7.26, HCO3 12, AG = Na - (Cl + HCO3) = 140 - (104 + 12) = 24 (elevated); lactate normal; ketones negative; normal renal function; osmol gap = measured - calculated = 295 - 290 = 5 (normal). The keyed answer C (pyroglutamic acidosis) fits: chronic acetaminophen depletes glutathione, and malnutrition/sepsis further impair the gamma-glutamyl cycle, leading to 5-oxoproline accumulation. The normal osmol gap correctly excludes methanol (A) and propylene glycol (D). D-lactic acidosis (B) is associated with short-gut syndrome or high carbohydrate loads, not this presentation. Salicylate toxicity (E) would typically cause a mixed respiratory alkalosis/metabolic acidosis and often presents with tachypnea, tinnitus, or coagulopathy—none mentioned. The stem provides sufficient detail to select a unique best answer. No contradictions. The explanation is accurate and aligns with current understanding of pyroglutamic acidosis pathophysiology. Minor nuance: the BUN/Cr ratio is not markedly elevated, but this does not detract from the core logic. The item is board-style and clinically realistic. Logical validity: V. Verdict: Correct best answer. Medical accuracy: accurate. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-004", "question": "A 34-year-old male presents with progressive dyspnea. He has a BMI of 17 kg/m2. Chest radiography shows apical pleural thickening. High-resolution CT demonstrates upper-lobe predominant subpleural fibrosis and a flattened chest configuration ('platythorax'). He has no history of asbestos exposure or connective tissue disease. Which of the following is the most likely diagnosis?", "options": ["Idiopathic Pulmonary Fibrosis (IPF)", "Pleuroparenchymal Fibroelastosis (PPFE)", "Chronic Hypersensitivity Pneumonitis", "Lymphangioleiomyomatosis (LAM)", "Pulmonary Alveolar Proteinosis"], "answer": "B", "answer_index": 1, "explanation": "Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural lung parenchyma, predominantly in the upper lobes. The radiographic hallmark is the 'platythorax' (flattening of the chest cage) due to fibrosis progression. This contrasts with IPF (lower lobe predominant) and Hypersensitivity Pneumonitis (mosaic attenuation, centrilobular nodules).", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem uniquely identifies Pleuroparenchymal Fibroelastosis (PPFE) through the combination of young age (34), low BMI (17 kg/m²), upper-lobe predominant subpleural fibrosis with apical pleural thickening, and characteristic 'platythorax' (flattened chest configuration). These features are classic for PPFE, a rare idiopathic interstitial pneumonia. Key discriminating clues exclude alternatives: IPF (A) is lower-lobe predominant in older patients; chronic hypersensitivity pneumonitis (C) typically shows mosaic attenuation/centrilobular nodules rather than pure fibrosis; LAM (D) occurs exclusively in young women with cystic disease; and alveolar proteinosis (E) presents with crazy-paving pattern, not fibrosis. No internal contradictions exist, and options permit clear discrimination based on pattern, demographics, and associated findings. Medical accuracy is excellent: the radiographic and demographic description aligns with current ATS/ERS consensus and published case series on PPFE. The item is board-style appropriate and teaches a recognizable rare entity. Minimal fix: None required; item is sound as written.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem uniquely identifies Pleuroparenchymal Fibroelastosis (PPFE) through the combination of young age (34), low BMI (17 kg/m²), upper-lobe predominant subpleural fibrosis with apical pleural thickening, and characteristic 'platythorax' (flattened chest configuration). These features are classic for PPFE, a rare idiopathic interstitial pneumonia. Key discriminating clues exclude alternatives: IPF (A) is lower-lobe predominant in older patients; chronic hypersensitivity pneumonitis (C) typically shows mosaic attenuation/centrilobular nodules rather than pure fibrosis; LAM (D) occurs exclusively in young women with cystic disease; and alveolar proteinosis (E) presents with crazy-paving pattern, not fibrosis. No internal contradictions exist, and options permit clear discrimination based on pattern, demographics, and associated findings. Medical accuracy is excellent: the radiographic and demographic description aligns with current ATS/ERS consensus and published case series on PPFE. The item is board-style appropriate and teaches a recognizable rare entity. Minimal fix: None required; item is sound as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-005", "question": "A 24-year-old African American male presents with cyanosis and shortness of breath after taking dapsone for a skin lesion. Pulse oximetry reads 85% and does not improve with supplemental oxygen. Arterial blood gas shows a normal PaO2 but methemoglobin level is 18%. He has a known history of hemolysis after ingesting fava beans. Which of the following is the most appropriate treatment?", "options": ["Methylene Blue 1 mg/kg IV", "Ascorbic Acid (Vitamin C) IV", "Hydroxocobalamin IV", "Hyperbaric Oxygen Therapy", "Sodium Thiosulfate IV"], "answer": "B", "answer_index": 1, "explanation": "The patient has methemoglobinemia precipitated by dapsone. However, his history of hemolysis with fava beans strongly suggests Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency. Methylene blue is contraindicated in G6PD deficiency because it requires NADPH (generated by G6PD) to reduce methemoglobin; without G6PD, methylene blue is ineffective and can induce severe hemolysis. Ascorbic acid (Vitamin C) or exchange transfusion is the appropriate management.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Stem provides classic discriminators: dapsone exposure, methemoglobin 18% with normal PaO2, and fava bean hemolysis history strongly implying G6PD deficiency. This uniquely contraindicates methylene blue (Option A), which requires NADPH via G6PD to reduce methemoglobin and would precipitate severe hemolysis. Options C, D, and E are incorrect as they target cyanide poisoning, not methemoglobinemia. Ascorbic acid (B) is the only remaining appropriate therapy; major guidelines confirm it as an alternative in G6PD deficiency, though slower-acting than methylene blue. No internal contradictions exist, and all options are mutually exclusive enough to permit clear discrimination. Medical accuracy is consistent with standard board expectations and major references (UpToDate, StatPearls). Minor limitation: the item doesn't state severity explicitly, but 18% methemoglobin with cyanosis/SOB implies moderate disease where specific therapy is reasonable over supportive care alone. Minimal fix: add 'moderate' before methemoglobinemia to justify pharmacologic intervention.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Stem provides classic discriminators: dapsone exposure, methemoglobin 18% with normal PaO2, and fava bean hemolysis history strongly implying G6PD deficiency. This uniquely contraindicates methylene blue (Option A), which requires NADPH via G6PD to reduce methemoglobin and would precipitate severe hemolysis. Options C, D, and E are incorrect as they target cyanide poisoning, not methemoglobinemia. Ascorbic acid (B) is the only remaining appropriate therapy; major guidelines confirm it as an alternative in G6PD deficiency, though slower-acting than methylene blue. No internal contradictions exist, and all options are mutually exclusive enough to permit clear discrimination. Medical accuracy is consistent with standard board expectations and major references (UpToDate, StatPearls). Minor limitation: the item doesn't state severity explicitly, but 18% methemoglobin with cyanosis/SOB implies moderate disease where specific therapy is reasonable over supportive care alone. Minimal fix: add 'moderate' before methemoglobinemia to justify pharmacologic intervention.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-006", "question": "A 14-year-old boy with a history of exercise-induced syncope is diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) confirmed by an RyR2 mutation. He is compliant with high-dose Nadolol. A repeat exercise stress test shows a reduction in arrhythmia burden, but he still develops runs of bidirectional ventricular tachycardia at peak exertion. Which of the following is the best next step in management?", "options": ["Switch Nadolol to Metoprolol Succinate", "Add Flecainide", "Perform Radiofrequency Ablation of the ventricular focus", "Implant a dual-chamber pacemaker", "Add Verapamil"], "answer": "B", "answer_index": 1, "explanation": "In patients with CPVT who have breakthrough arrhythmias despite optimal beta-blocker therapy (preferably Nadolol or Propranolol), the addition of Flecainide is the guideline-recommended next step. Flecainide has a direct blocking effect on the cardiac ryanodine receptor (RyR2), addressing the underlying mechanism. Radiofrequency ablation is generally ineffective due to the polymorphic/multifocal nature of the arrhythmia.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": \",\"logical_false_reason\":\"T\",\"logical_validity\":true,\"medical_accuracy_score\":\"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": ", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-007", "question": "A 26-year-old female with a history of sensorineural hearing loss and short stature presents with acute onset aphasia and right-sided hemiparesis. MRI shows a T2-hyperintense lesion in the left temporal lobe that does not conform to a vascular territory. Serum lactate is elevated. Which of the following agents is indicated for the acute management of this condition?", "options": ["Intravenous Tissue Plasminogen Activator (tPA)", "Intravenous Arginine", "Intravenous Heparin", "High-dose Aspirin", "Plasma Exchange"], "answer": "B", "answer_index": 1, "explanation": "The clinical picture (stroke-like episode not respecting vascular territories, hearing loss, elevated lactate) is classic for MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). The stroke-like episodes are due to metabolic failure and microvascular angiopathy (nitric oxide deficiency), not thrombotic occlusion. Intravenous Arginine is the recommended acute treatment to improve nitric oxide availability and cerebral blood flow. tPA is not indicated and could be harmful.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem's key discriminators—sensorineural hearing loss, short stature, non-vascular MRI lesion pattern, and elevated lactate in a young adult—classically define MELAS syndrome. The acute stroke-like episode stems from metabolic failure and microvascular dysfunction, not thrombosis. IV arginine (B) is the consensus acute therapy to augment nitric oxide and cerebral perfusion. Alternatives are clearly inferior: tPA (A) is contraindicated and potentially harmful without thrombotic occlusion; heparin (C) and high-dose aspirin (D) target inappropriate pathophysiology; plasma exchange (E) lacks indication. No logical flaws: a single best answer is uniquely defensible, options permit clear discrimination, and the key matches it. Medical accuracy aligns with current mitochondrial disease guidelines, though the arginine recommendation rests on observational data rather than large RCTs. No contradictions or underspecification. Minimal fix: None required; item is board-examination ready as written.\",\"medical_accuracy_score\":  \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem's key discriminators—sensorineural hearing loss, short stature, non-vascular MRI lesion pattern, and elevated lactate in a young adult—classically define MELAS syndrome. The acute stroke-like episode stems from metabolic failure and microvascular dysfunction, not thrombosis. IV arginine (B) is the consensus acute therapy to augment nitric oxide and cerebral perfusion. Alternatives are clearly inferior: tPA (A) is contraindicated and potentially harmful without thrombotic occlusion; heparin (C) and high-dose aspirin (D) target inappropriate pathophysiology; plasma exchange (E) lacks indication. No logical flaws: a single best answer is uniquely defensible, options permit clear discrimination, and the key matches it. Medical accuracy aligns with current mitochondrial disease guidelines, though the arginine recommendation rests on observational data rather than large RCTs. No contradictions or underspecification. Minimal fix: None required; item is board-examination ready as written.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-008", "question": "A 32-year-old female is evaluated for palpitations. Labs reveal a TSH of 7.2 mIU/L (High) and Free T4 of 2.9 ng/dL (High). An MRI of the pituitary shows a 5mm hypoenhancing lesion. Sex Hormone Binding Globulin (SHBG) levels are elevated. Which of the following is the most likely diagnosis?", "options": ["Resistance to Thyroid Hormone (RTH) beta", "TSH-secreting pituitary adenoma (TSHoma)", "Graves' disease", "Familial Dysalbuminemic Hyperthyroxinemia", "Heterophile antibody interference"], "answer": "B", "answer_index": 1, "explanation": "Both RTH and TSHoma present with inappropriate TSH secretion (high T4, non-suppressed TSH). The key differentiator is the peripheral tissue response. In TSHoma, peripheral tissues (like the liver) are sensitive to the high thyroid hormone levels, resulting in elevated markers of thyroid action such as Sex Hormone Binding Globulin (SHBG). In RTH, the peripheral tissues are resistant, so SHBG levels are typically normal. The pituitary lesion supports TSHoma, but incidentalomas are common; the metabolic profile (high SHBG) confirms the diagnosis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem provides classic discriminators: inappropriate TSH secretion (high TSH + high free T4) combined with elevated SHBG and a pituitary lesion. This constellation uniquely identifies a TSH-secreting pituitary adenoma (TSHoma), as the elevated SHBG confirms intact peripheral thyroid hormone action, distinguishing it from thyroid hormone resistance (RTH) where SHBG would be normal. The 5mm hypoenhancing lesion, while possibly incidental, becomes clinically significant when paired with the biochemical profile. Alternative options are appropriately excluded: RTH lacks SHBG elevation and would not have a pituitary lesion; Graves' disease would show suppressed TSH; familial dysalbuminemic hyperthyroxinemia affects total T4 but not free T4; and heterophile antibodies cannot explain the pituitary lesion or metabolic marker. The item is logically valid with a single best answer that matches the key. Medical accuracy is sound, correctly applying the principle that peripheral markers like SHBG differentiate central versus peripheral resistance patterns. The teaching point is board-relevant and reflects current endocrine standards for evaluating inappropriate TSH secretion in a clinically realistic scenario. No contradictions, underspecification, or content errors are present. The item requires no revision at all.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem provides classic discriminators: inappropriate TSH secretion (high TSH + high free T4) combined with elevated SHBG and a pituitary lesion. This constellation uniquely identifies a TSH-secreting pituitary adenoma (TSHoma), as the elevated SHBG confirms intact peripheral thyroid hormone action, distinguishing it from thyroid hormone resistance (RTH) where SHBG would be normal. The 5mm hypoenhancing lesion, while possibly incidental, becomes clinically significant when paired with the biochemical profile. Alternative options are appropriately excluded: RTH lacks SHBG elevation and would not have a pituitary lesion; Graves' disease would show suppressed TSH; familial dysalbuminemic hyperthyroxinemia affects total T4 but not free T4; and heterophile antibodies cannot explain the pituitary lesion or metabolic marker. The item is logically valid with a single best answer that matches the key. Medical accuracy is sound, correctly applying the principle that peripheral markers like SHBG differentiate central versus peripheral resistance patterns. The teaching point is board-relevant and reflects current endocrine standards for evaluating inappropriate TSH secretion in a clinically realistic scenario. No contradictions, underspecification, or content errors are present. The item requires no revision at all.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-009", "question": "A 48-year-old male who works as a tool grinder presents with chronic dry cough and dyspnea. Bronchoalveolar lavage (BAL) reveals multinucleated giant cells that appear to be engulfing other cells ('cannibalistic' giant cells). Which of the following exposures is most likely responsible for this finding?", "options": ["Silica", "Asbestos", "Cobalt", "Beryllium", "Coal dust"], "answer": "C", "answer_index": 2, "explanation": "The presence of 'cannibalistic' multinucleated giant cells in BAL or biopsy is pathognomonic for Hard Metal Lung Disease (Giant Cell Interstitial Pneumonia). This is caused by exposure to Cobalt, often in the form of tungsten carbide alloy used in tool grinding, diamond polishing, or saw sharpening. Beryllium causes granulomas similar to sarcoidosis, not GIP.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer (Cobalt) is the correct best choice. Key stem clues: (1) Occupation as tool grinder → exposure to tungsten carbide/cobalt dust; (2) Chronic dry cough and dyspnea suggest interstitial lung disease; (3) BAL reveals multinucleated giant cells engulfing other cells ('cannibalistic'), a pathognomonic feature of giant cell interstitial pneumonia (GIP) in hard metal lung disease. These three elements converge uniquely on cobalt inhalation. Alternative options: Silica causes silicosis with fibrotic nodules, not GIP; asbestos leads to asbestosis/pleural disease; coal dust produces coal workers’ pneumoconiosis; beryllium induces sarcoid-like granulomas, none showing cannibalistic giant cells. Thus, only cobalt fits. No internal contradictions or missing critical details. Medical accuracy: The item accurately reflects current occupational lung disease consensus that cobalt exposure in hard metal industries causes GIP, and the 'cannibalistic' giant cell descriptor is a recognized board-level clue. No safety concerns or outdated guidance. Minimal fix: None required.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer (Cobalt) is the correct best choice. Key stem clues: (1) Occupation as tool grinder → exposure to tungsten carbide/cobalt dust; (2) Chronic dry cough and dyspnea suggest interstitial lung disease; (3) BAL reveals multinucleated giant cells engulfing other cells ('cannibalistic'), a pathognomonic feature of giant cell interstitial pneumonia (GIP) in hard metal lung disease. These three elements converge uniquely on cobalt inhalation. Alternative options: Silica causes silicosis with fibrotic nodules, not GIP; asbestos leads to asbestosis/pleural disease; coal dust produces coal workers’ pneumoconiosis; beryllium induces sarcoid-like granulomas, none showing cannibalistic giant cells. Thus, only cobalt fits. No internal contradictions or missing critical details. Medical accuracy: The item accurately reflects current occupational lung disease consensus that cobalt exposure in hard metal industries causes GIP, and the 'cannibalistic' giant cell descriptor is a recognized board-level clue. No safety concerns or outdated guidance. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-010", "question": "A 52-year-old male presents to the ED 2 hours after ingesting a massive overdose of sustained-release Verapamil. He is hypotensive (BP 60/40 mmHg) and bradycardic (HR 38 bpm). He remains hypotensive despite 3 liters of crystalloid, IV Calcium Gluconate, and IV Glucagon. Which of the following is the most appropriate next therapeutic intervention?", "options": ["High-dose Insulin Euglycemia therapy", "Transvenous Pacing", "Hemodialysis", "IV Amiodarone", "IV Lipid Emulsion (20%)"], "answer": "A", "answer_index": 0, "explanation": "High-dose Insulin Euglycemia (HIE) is the recommended therapy for severe calcium channel blocker toxicity refractory to initial measures (fluids, calcium). Insulin has a positive inotropic effect and improves myocardial glucose utilization in the stressed heart. While lipid emulsion is a salvage therapy, HIE has stronger evidence as a first-line pharmacologic support after calcium/fluids. Transvenous pacing often fails to capture or improve cardiac output in severe CCB poisoning due to global myocardial depression.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: 52-year-old male, massive sustained-release verapamil overdose, severe refractory hypotension (BP 60/40) and bradycardia (HR 38) persisting after 3 L crystalloid, IV calcium gluconate, and IV glucagon. These features signal severe calcium channel blocker (CCB) toxicity with cardiogenic shock. The most appropriate next therapeutic intervention is high-dose insulin euglycemia (HIE) therapy, which provides potent inotropic support, enhances myocardial glucose uptake, and is endorsed by major toxicology guidelines as first-line advanced therapy for CCB poisoning refractory to initial measures. Alternative critique: Transvenous pacing (B) frequently fails to capture due to global myocardial depression; hemodialysis (C) is ineffective because verapamil has a large volume of distribution and high protein binding; IV amiodarone (D) is contraindicated and irrelevant to CCB toxicity; IV lipid emulsion (E) is a salvage therapy with less robust evidence than HIE and is reserved for cases refractory to HIE and vasopressors. The stem contains no internal contradictions and provides adequate discriminators. Medical accuracy: The keyed answer aligns with current ACMT/AACT consensus and is board-relevant. Minimal fix: None required.\",\"logical_false_reason\":\"T\",\"logical_validity\":true,\"medical_accuracy_score\":\"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: 52-year-old male, massive sustained-release verapamil overdose, severe refractory hypotension (BP 60/40) and bradycardia (HR 38) persisting after 3 L crystalloid, IV calcium gluconate, and IV glucagon. These features signal severe calcium channel blocker (CCB) toxicity with cardiogenic shock. The most appropriate next therapeutic intervention is high-dose insulin euglycemia (HIE) therapy, which provides potent inotropic support, enhances myocardial glucose uptake, and is endorsed by major toxicology guidelines as first-line advanced therapy for CCB poisoning refractory to initial measures. Alternative critique: Transvenous pacing (B) frequently fails to capture due to global myocardial depression; hemodialysis (C) is ineffective because verapamil has a large volume of distribution and high protein binding; IV amiodarone (D) is contraindicated and irrelevant to CCB toxicity; IV lipid emulsion (E) is a salvage therapy with less robust evidence than HIE and is reserved for cases refractory to HIE and vasopressors. The stem contains no internal contradictions and provides adequate discriminators. Medical accuracy: The keyed answer aligns with current ACMT/AACT consensus and is board-relevant. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]